BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 25922306)

  • 1. The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development.
    Yang Q; Mas A; Diamond MP; Al-Hendy A
    Reprod Sci; 2016 Feb; 23(2):163-75. PubMed ID: 25922306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma.
    Navarro A; Yin P; Monsivais D; Lin SM; Du P; Wei JJ; Bulun SE
    PLoS One; 2012; 7(3):e33284. PubMed ID: 22428009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenomic and enhancer dysregulation in uterine leiomyomas.
    Mlodawska OW; Saini P; Parker JB; Wei JJ; Bulun SE; Simon MA; Chakravarti D
    Hum Reprod Update; 2022 Jun; 28(4):518-547. PubMed ID: 35199155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease.
    Laganà AS; Vergara D; Favilli A; La Rosa VL; Tinelli A; Gerli S; Noventa M; Vitagliano A; Triolo O; Rapisarda AMC; Vitale SG
    Arch Gynecol Obstet; 2017 Nov; 296(5):855-867. PubMed ID: 28875276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
    Commandeur AE; Styer AK; Teixeira JM
    Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide DNA methylation analysis reveals a potential mechanism for the pathogenesis and development of uterine leiomyomas.
    Maekawa R; Sato S; Yamagata Y; Asada H; Tamura I; Lee L; Okada M; Tamura H; Takaki E; Nakai A; Sugino N
    PLoS One; 2013; 8(6):e66632. PubMed ID: 23818951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation and gene hypermethylation of the 14-3-3 gamma in uterine leiomyoma.
    Jiang W; Luo H; Shen Z; Zhang W; Chen A; Zhu X
    Front Biosci (Landmark Ed); 2016 Jun; 21(6):1286-95. PubMed ID: 27100507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth.
    Ono M; Yin P; Navarro A; Moravek MB; Coon JS; Druschitz SA; Serna VA; Qiang W; Brooks DC; Malpani SS; Ma J; Ercan CM; Mittal N; Monsivais D; Dyson MT; Yemelyanov A; Maruyama T; Chakravarti D; Kim JJ; Kurita T; Gottardi CJ; Bulun SE
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17053-8. PubMed ID: 24082114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different methylation levels in the KLF4, ATF3 and DLEC1 genes in the myometrium and in corpus uteri mesenchymal tumours as assessed by MS-HRM.
    Braný D; Dvorská D; Grendár M; Ňachajová M; Szépe P; Lasabová Z; Žúbor P; Višňovský J; Halášová E
    Pathol Res Pract; 2019 Aug; 215(8):152465. PubMed ID: 31176573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H19 lncRNA identified as a master regulator of genes that drive uterine leiomyomas.
    Cao T; Jiang Y; Wang Z; Zhang N; Al-Hendy A; Mamillapalli R; Kallen AN; Kodaman P; Taylor HS; Li D; Huang Y
    Oncogene; 2019 Jul; 38(27):5356-5366. PubMed ID: 31089260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential mechanisms of aberrant DNA hypomethylation on the x chromosome in uterine leiomyomas.
    Sato S; Maekawa R; Yamagata Y; Asada H; Tamura I; Lee L; Okada M; Tamura H; Sugino N
    J Reprod Dev; 2014 Mar; 60(1):47-54. PubMed ID: 24291816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Hydroxymethylcytosine promotes proliferation of human uterine leiomyoma: a biological link to a new epigenetic modification in benign tumors.
    Navarro A; Yin P; Ono M; Monsivais D; Moravek MB; Coon JS; Dyson MT; Wei JJ; Bulun SE
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2437-45. PubMed ID: 25057885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H3K4me3 mediates uterine leiomyoma pathogenesis via neuronal processes, synapsis components, proliferation, and Wnt/β-catenin and TGF-β pathways.
    Carbajo-García MC; Juarez-Barber E; Segura-Benítez M; Faus A; Trelis A; Monleón J; Carmona-Antoñanzas G; Pellicer A; Flanagan JM; Ferrero H
    Reprod Biol Endocrinol; 2023 Jan; 21(1):9. PubMed ID: 36703136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Leiomyomas of the uterine body: Molecular-genetical aspects of formation and development].
    Dvorská D; Višňovský J; Braný D; Danko J
    Ceska Gynekol; 2016 Jan; 81(1):48-52. PubMed ID: 26982065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative analysis of the DNA methylome and transcriptome in uterine leiomyoma shows altered regulation of genes involved in metabolism, proliferation, extracellular matrix, and vesicles.
    Carbajo-García MC; Corachán A; Juárez-Barber E; Monleón J; Payá V; Trelis A; Quiñonero A; Pellicer A; Ferrero H
    J Pathol; 2022 Aug; 257(5):663-673. PubMed ID: 35472162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of erythropoietin messenger ribonucleic acid in wild-type MED12 uterine leiomyomas under estrogenic influence: new insights into related growth disparities.
    Asano R; Asai-Sato M; Matsukuma S; Mizushima T; Taguri M; Yoshihara M; Inada M; Fukui A; Suzuki Y; Miyagi Y; Miyagi E
    Fertil Steril; 2019 Jan; 111(1):178-185. PubMed ID: 30554729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas.
    Yu L; Saile K; Swartz CD; He H; Zheng X; Kissling GE; Di X; Lucas S; Robboy SJ; Dixon D
    Mol Med; 2008; 14(5-6):264-75. PubMed ID: 18231572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficient H2A.Z deposition is associated with genesis of uterine leiomyoma.
    Berta DG; Kuisma H; Välimäki N; Räisänen M; Jäntti M; Pasanen A; Karhu A; Kaukomaa J; Taira A; Cajuso T; Nieminen S; Penttinen RM; Ahonen S; Lehtonen R; Mehine M; Vahteristo P; Jalkanen J; Sahu B; Ravantti J; Mäkinen N; Rajamäki K; Palin K; Taipale J; Heikinheimo O; Bützow R; Kaasinen E; Aaltonen LA
    Nature; 2021 Aug; 596(7872):398-403. PubMed ID: 34349258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Mechanisms Driving Uterine Leiomyoma Pathobiology, Epidemiology, and Treatment.
    Ramaiyer MS; Saad E; Kurt I; Borahay MA
    Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of Cyr61, a member of the CCN (CTGF/Cyr61/Cef10/NOVH) family, and dysregulation by 17 beta-estradiol and basic fibroblast growth factor in human uterine leiomyomas.
    Sampath D; Zhu Y; Winneker RC; Zhang Z
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1707-15. PubMed ID: 11297607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.